Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
22,278,088
-
Total 13F shares
-
7,973,561
-
Share change
-
-118,596
-
Total reported value
-
$324,820,687
-
Put/Call ratio
-
36%
-
Price per share
-
$40.74
-
Number of holders
-
135
-
Value change
-
-$11,764,194
-
Number of buys
-
59
-
Number of sells
-
89
Institutional Holders of ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) as of Q1 2020
As of 31 Mar 2020,
ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) was held by
135 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,973,561 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, MANGROVE PARTNERS, STATE STREET CORP, INVESTMENT COUNSELORS OF MARYLAND LLC, GOLDMAN SACHS GROUP INC, FIRST MANHATTAN CO, Invesco Ltd., and RENAISSANCE TECHNOLOGIES LLC.
This page lists
135
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.